Free Trial
NYSE:PBH

Prestige Consumer Healthcare (PBH) Stock Price, News & Analysis

Prestige Consumer Healthcare logo
$82.67 +0.21 (+0.25%)
(As of 11/20/2024 ET)

About Prestige Consumer Healthcare Stock (NYSE:PBH)

Key Stats

Today's Range
$81.33
$82.74
50-Day Range
$67.53
$82.81
52-Week Range
$56.61
$83.83
Volume
242,053 shs
Average Volume
251,384 shs
Market Capitalization
$4.08 billion
P/E Ratio
20.11
Dividend Yield
N/A
Price Target
$83.67
Consensus Rating
Moderate Buy

Company Overview

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.

Prestige Consumer Healthcare Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
68th Percentile Overall Score

PBH MarketRank™: 

Prestige Consumer Healthcare scored higher than 68% of companies evaluated by MarketBeat, and ranked 319th out of 963 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Prestige Consumer Healthcare has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Prestige Consumer Healthcare has only been the subject of 2 research reports in the past 90 days.

  • Read more about Prestige Consumer Healthcare's stock forecast and price target.
  • Earnings Growth

    Earnings for Prestige Consumer Healthcare are expected to grow by 6.74% in the coming year, from $4.45 to $4.75 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Prestige Consumer Healthcare is 20.11, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 131.16.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Prestige Consumer Healthcare is 20.11, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 126.31.

  • Price to Earnings Growth Ratio

    Prestige Consumer Healthcare has a PEG Ratio of 2.32. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Prestige Consumer Healthcare has a P/B Ratio of 2.48. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Prestige Consumer Healthcare's valuation and earnings.
  • Percentage of Shares Shorted

    4.86% of the float of Prestige Consumer Healthcare has been sold short.
  • Short Interest Ratio / Days to Cover

    Prestige Consumer Healthcare has a short interest ratio ("days to cover") of 9.8.
  • Change versus previous month

    Short interest in Prestige Consumer Healthcare has recently increased by 12.32%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Prestige Consumer Healthcare does not currently pay a dividend.

  • Dividend Growth

    Prestige Consumer Healthcare does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    4.86% of the float of Prestige Consumer Healthcare has been sold short.
  • Short Interest Ratio / Days to Cover

    Prestige Consumer Healthcare has a short interest ratio ("days to cover") of 9.8.
  • Change versus previous month

    Short interest in Prestige Consumer Healthcare has recently increased by 12.32%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Prestige Consumer Healthcare has a news sentiment score of 0.40. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for Prestige Consumer Healthcare this week, compared to 4 articles on an average week.
  • MarketBeat Follows

    3 people have added Prestige Consumer Healthcare to their MarketBeat watchlist in the last 30 days. This is an increase of 50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Prestige Consumer Healthcare insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,289,025.00 in company stock.

  • Percentage Held by Insiders

    Only 1.60% of the stock of Prestige Consumer Healthcare is held by insiders.

  • Percentage Held by Institutions

    99.95% of the stock of Prestige Consumer Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Prestige Consumer Healthcare's insider trading history.
Receive PBH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Prestige Consumer Healthcare and its competitors with MarketBeat's FREE daily newsletter.

PBH Stock News Headlines

New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar
As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.
See More Headlines

PBH Stock Analysis - Frequently Asked Questions

Prestige Consumer Healthcare's stock was trading at $61.22 at the beginning of 2024. Since then, PBH stock has increased by 35.0% and is now trading at $82.67.
View the best growth stocks for 2024 here
.

Prestige Consumer Healthcare Inc. (NYSE:PBH) issued its quarterly earnings results on Thursday, November, 7th. The company reported $1.09 EPS for the quarter, hitting analysts' consensus estimates of $1.09. The firm's revenue was down .9% compared to the same quarter last year.

Prestige Consumer Healthcare's top institutional shareholders include Victory Capital Management Inc. (4.17%), State Street Corp (4.06%), Allspring Global Investments Holdings LLC (3.18%) and Geode Capital Management LLC (2.69%). Insiders that own company stock include Ronald M Lombardi, William P'pool, Mary Beth Fritz and Adel Mekhail.
View institutional ownership trends
.

Shares of PBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Prestige Consumer Healthcare investors own include American Water Works (AWK), Waste Connections (WCN), Humana (HUM), The RMR Group (RMR), DiamondRock Hospitality (DRH), Voyager Therapeutics (VYGR) and AUO (AUOTY).

Company Calendar

Last Earnings
11/07/2024
Today
11/20/2024
Next Earnings (Estimated)
2/13/2025
Fiscal Year End
3/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Personal Products
CUSIP
74112D10
Employees
540
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$83.67
High Stock Price Target
$95.00
Low Stock Price Target
$76.00
Potential Upside/Downside
+1.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
3 Analysts

Profitability

Net Income
$209.34 million
Pretax Margin
24.04%

Debt

Sales & Book Value

Annual Sales
$1.13 billion
Cash Flow
$5.00 per share
Book Value
$33.34 per share

Miscellaneous

Free Float
48,615,000
Market Cap
$4.08 billion
Optionable
Optionable
Beta
0.47

Social Links

5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NYSE:PBH) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners